Skip to main content

Showing results for Research Funding

IU School of Medicine's 2023 NIH funding ranked No. 13 among public universities

Indiana University School of Medicine researchers received over $243 million in total funding from the National Institutes of Health during federal fiscal year 2023 — a more than $54 million increase over the past five years, or 28%.

IU School of Medicine  |  Feb 20, 2024

$3.4 million grant to fund research on brain bleeding, swelling that occurs in quarter of patients who receive Alzheimer’s disease treatments

With the emergence of promising treatments that slow the cognitive decline of Alzheimer’s disease in patients, there are still questions surrounding side effects of the drugs. An Indiana University School of Medicine researcher is among the few neuroscientists investigating these adverse events, which can cause brain swelling and brain bleeding.

IU School of Medicine  |  Feb 14, 2024

IU surgeon-scientist studying physiological effect of microorganisms in sinuses of chronic rhinosinusitis patients

An Indiana University School of Medicine surgeon-scientist is leading a multi-institutional grant investigating the role of the sinus microbiome in chronic rhinosinusitis, an inflammatory disease that causes the lining of the sinuses to swell.

IU School of Medicine  |  Feb 01, 2024

New research aims to develop novel therapeutic for glaucoma

INDIANAPOLIS—Researchers at Indiana University School of Medicine are using a novel approach to hopefully develop a new therapy for glaucoma, a complex disease that eventually leads to blindness, thanks to a new five-year, $2 million R01 grant from the National Eye Institute.

IU School of Medicine  |  Jan 04, 2024

Beta blocker used to treat heart problems and other medical concerns could be new treatment for sickle cell cardiomyopathy

A beta blocker typically used to treat heart problems, hemangioma, migraines and anxiety could be a new therapeutic for patients with sickle cell disease.

IU School of Medicine  |  Jan 03, 2024

Lung cancer screenings to expand for Indiana veterans thanks to $1 million grant

Two researchers with the Indiana University Melvin and Bren Simon Comprehensive Cancer Center and the Richard L. Roudebush Veterans Administration Medical Center have been awarded a three-year, $1 million grant to expand lung cancer screenings to veterans across Indiana.

IU Simon Comprehensive Cancer Center  |  Dec 13, 2023

$3.9 million grant funds research on maternal influence in children’s allergy development

A five-year, $3.9 million grant will enable Indiana University School of Medicine researchers to explore how allergies and asthma may be passed from mothers to their children, presenting a better understanding of how allergies develop and paving the way for transformative approaches to allergy prevention and management. 

IU awarded $5 million grant to find ways to transform adolescent opioid use disorder care in Indiana

IU School of Medicine researchers are taking steps to improve the accessibility and quality of care for adolescents experiencing opioid use disorder (OUD) and other substance use disorders (SUDs), thanks to a new $5 million grant from the National Institute of Health’s Helping to End Addiction Long-Term (HEAL) Initiative.

IU School of Medicine  |  Nov 14, 2023

IU leukemia expert awarded $1 million grant from Leukemia and Lymphoma Society

An Indiana University leukemia physician-scientist has been awarded a $1 million grant from the Leukemia and Lymphoma Society to evaluate a new treatment for an extremely rare and incurable blood cancer.

IU Simon Comprehensive Cancer Center  |  Nov 09, 2023

IU Simon Comprehensive Cancer Center researchers receive $2.4 million NCI grant to develop new pancreatic cancer treatments

Two researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have received a five-year, $2.4 million grant from the National Cancer Institute (NCI) to explore new therapies that target the critical pathways pancreatic tumors use to survive.

IU Simon Comprehensive Cancer Center  |  Nov 06, 2023